JAKARTA, May 16 (Reuters): Indonesia has suspended distribution of a batch of AstraZeneca PLC's novel coronavirus vaccine to run tests for sterility and toxicity following the death of a 22-year-old man a day after immunisation, the health ministry said on Sunday.
The "CTMAV547" batch consists of 448,480 vaccine doses that arrived in the Southeast Asian nation last month - part of a delivery of more than 3.85 million doses from the COVAX Facility, backed by the World Health Organisation.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!